OXiGENE Inc. (OXGN) Stock Quote

Detailed Quote for OXiGENE Inc. (OXGN) 
$ 1.16   -0.07 (-5.69%) Volume: 325.36 k 3:02 PM EST Feb 10, 2012
Today 5d 1m 3m 1y more
Last Price
1.16
Change $
0.07
Change %
5.69%
Tick
  
Bid
1.16
Bid Size
10,000
Ask
1.17
Ask Size
1,100
Open
1.23
High
1.2599
Low
1.159
Prev Close
1.23
Last Trade
3:02
Volume
325.36 k
52 Wk Hi
6.38
52 Wk Low
0.82
Market Cap
17.26 m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
14,879,857
EPS (TTM)
-0.46
PE Ratio
N/A
Exchange
NSC
News and Media for OXiGENE Inc.  (OXGN) 
Sector News | Topic News
News for OXGN
Tue, Feb 07, 2012
8:20 AM Biotech Sector Shows No Signs of Slowing -- OXiGENE and Generex Poised for Growth - Marketwire
Mon, Feb 06, 2012
8:01 AM OXiGENE to Present at BIO CEO & Investor Conference - Globe Newswire
Mon, Dec 12, 2011
8:00 AM OXiGENE and Azanta A/S Establish Partnership to Provide ZYBRESTAT(TM) for ATC in Europe on Named Patient, Compassionate Use Basis - Globe Newswire
Wed, Dec 07, 2011
8:00 AM OXiGENE Presents Data From FAVOR Study of ZYBRESTAT in PCV - Globe Newswire
Mon, Dec 05, 2011
8:16 AM Marina Biotech and OXiGENE Supported by Strong Clinical Programs - Marketwire
Tue, Nov 29, 2011
7:05 AM MerrillEquities.com Issues Trading Outlook on Hottest Stocks in Today's Market: DEXO, OXGN, GALE - Accesswire
Mon, Nov 28, 2011
8:30 AM OXiGENE Announces Purchase Agreement for Up to $20 Million With Lincoln Park Capital - Globe Newswire
Wed, Nov 09, 2011
4:01 PM OXiGENE Reports Third Quarter 2011 Financial Results - Globe Newswire
Thu, Nov 03, 2011
4:30 PM OXiGENE Reports Final Data From Phase 2 FALCON Study of ZYBRESTAT in Non-Small Cell Lung Cancer - Globe Newswire
Wed, Nov 02, 2011
7:00 AM OXiGENE Announces Third Quarter 2011 Earnings Conference Call and Webcast - Globe Newswire
Fri, Oct 21, 2011
8:16 AM OXiGENE and Neoprobe Reawaken Investor Interest in Biotechnology Industry - Marketwire
Wed, Sep 14, 2011
1:18 PM OXiGENE Presents Data Confirming Survival Benefit of ZYBRESTAT in Patients With Anaplastic Thyroid Cancer - Globe Newswire
Fri, Sep 09, 2011
4:00 PM OXiGENE Announces Changes to Board of Directors - Globe Newswire
Wed, Sep 07, 2011
4:34 PM OXiGENE to Present Additional ZYBRESTAT(TM) Survival Data at European Thyroid Association Annual Meeting - Globe Newswire
8:16 AM Marina Biotech and OXiGENE Attack Cancer From Different Angles - Marketwire
Thu, Sep 01, 2011
8:00 AM OXiGENE Announces Restructuring to Focus Resources on Promising Earlier Stage Clinical Programs - Globe Newswire
Wed, Aug 10, 2011
4:01 PM OXiGENE Reports Second Quarter 2011 Financial Results - Globe Newswire
Wed, Jun 15, 2011
8:16 AM Ariad and OXiGENE Show Encouraging Growth Potential - Marketwire
Mon, Jun 06, 2011
4:45 PM ZYBRESTAT(TM) Results Suggest Improvement in Overall Survival in Phase 2/3 Study in Anaplastic Thyroid Cancer - Globe Newswire
8:00 AM OXiGENE Complies With NASDAQ Listing Requirements - Globe Newswire
More News for OXGN >>

Tags for OXiGENE Inc.

Research stocks or mutual funds related to OXiGENE Inc. by keywords or tags. Find companies that have a similar focus to OXGN. The keywords below have been associated to OXGN by either user submission or electronic means.

stock market symbol flash intro builder flash banner creator flash web pages flash banner builder online stock quote pivotal therapy system Commercial Physical And Biological Research (8731) live stock quote financial stock market flash intro software stock market ticker alternative leukemia treatment angiogenesis inhibitors Biological Products chemotherapy stock quote nasdaq quote oncology treatment create flash animation nyse stock quote chemotherapy breast cancer stock market quotes nasdaq quotes stock quote software immune stock price quote instant stock quotes Drugs flash banner maker create flash intro nasdaq stocks nasdaq stock market quotes stock charts siri stock stock ticker after hours stock price data oncology stocks quote hairy cell leukemia therapy streaming stock prices nasdaq stock quotes historical stock quotes current stock quotes flash web canada stock quote therapy live cell therapy colon cancer chemotherapy live stock prices